Ebola vaccination trial launched in Uganda, WHO says
ReutersFeb 3, 2025 8:59 PM
Feb 3 (Reuters) - The World Health Organization (WHO) on Monday said that it has launched a first ever vaccine trial in Uganda for Ebola from the Sudan species of the virus.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
[Reuters Breakingviews] ‘Big Beautiful Bill’ portends vast ugly costs
WASHINGTON, July 1 (Reuters Breakingviews) - Donald Trump just won the most Pyrrhic of victories. The Republican-controlled Senate on Tuesday narrowly passed the U.S. president’s budget proposal, misleadingly dubbed the “One Big Beautiful Bill.” It mortgages the country’s future ...Reuters
7 minutes ago
Should You Buy Microsoft Stock Now or Wait for a Dip?
Shares of Microsoft (NASDAQ: MSFT) are up 18% this year (returns as of June 27), and that has pushed the stock to a new all-time high. It's been a traditionally safe stock to own, but it's definitely expensive these days, trading at around 38 times its trailing earnings.The Motley Fool
20 minutes ago
Why Nike Stock Raced Ahead Today
Athletic apparel and footwear star Nike (NYSE: NKE) notched a stock market victory for its investors on Tuesday with a more than 3% increase in share price.The Motley Fool
23 minutes ago
Prediction! Federal Reserve Chairman Jerome Powell's Next Move Will Be an Interest Rate Cut
The Federal Reserve must balance the risks of higher inflation with the risks of higher unemployment when making decisions on interest rates.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were..The Motley Fool
Thu, Jun 26
U.S. Big Banks Earnings Q1 2025: Profits Amidst Worries, A Tale of Trump's Mixed Influence?
TradingKey - Against the backdrop of President Donald Trump’s "deregulation" agenda, Wall Street’s major banks have yet to stage a significant rally in early 2025. However, buoyed by high interest rates and policy uncertainty under the Trump administration, the Q1 earnings reports from the six...TradingKey
Fri, Apr 18
Tradingkey
